Frontiers in Medicine | Regulatory Science

Original Research

Published on 11 Mar 2024

Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation

in Regulatory Science

Hiam Chemaitelly
Houssein H. Ayoub
Patrick Tang
Hadi M. Yassine
Asmaa A. Al Thani
Mohammad R. Hasan
Peter Coyle
Zaina Al-Kanaani
Einas Al-Kuwari
Andrew Jeremijenko

Frontiers in Medicine

doi 10.3389/fmed.2024.1363045

3,103 views
14 citations

Editorial

Published on 08 Mar 2024

Editorial: Women in science - regulatory science 2023

in Regulatory Science

Mette Due Theilade Thomsen
Lisbeth Ehlert Knudsen

Frontiers in Medicine

doi 10.3389/fmed.2024.1389438

1,629 views

Original Research

Published on 06 Mar 2024

Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors

in Regulatory Science

Young-Sang Kim
Anhye Kim
Yil-Seob Lee

Frontiers in Medicine

doi 10.3389/fmed.2024.1342184

8,376 views
1 citation

Policy and Practice Reviews

Published on 06 Mar 2024

Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators

in Regulatory Science

Philipp Cimiano
Ben Collins
Maria Carmela De Vuono
Thierry Escudier
Jürgen Gottowik
Matthias Hartung
Mathias Leddin
Bikalpa Neupane
Raul Rodriguez-Esteban
Ana Lucia Schmidt

Frontiers in Medicine

doi 10.3389/fmed.2024.1274688

9,022 views
19 citations

Editorial

Published on 27 Feb 2024

Editorial: Reproductive medical care in minors: ethical and liability issues

in Regulatory Science

Mariano Cingolani
Vittoradolfo Tambone

Frontiers in Medicine

doi 10.3389/fmed.2024.1378211

2,958 views

Original Research

Published on 19 Feb 2024

Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated

in Regulatory Science

Ming Kei Lee
Sama Seyedmousavi
Sylvain Auvity
Bertrand Pourroy
Vincent Elleboode
Isabelle Kachaner
Christel Jansen
Herve Lilliu

Frontiers in Medicine

doi 10.3389/fmed.2024.1324602

5,203 views
4 citations

Original Research

Published on 15 Feb 2024

Data from the Indian drug regulator and from Clinical Trials Registry-India does not always match

in Regulatory Science

Iqbal S. Bhalla
Adithi Gopadi Ravindranath
Ravi Vaswani
Gayatri Saberwal

Frontiers in Medicine

doi 10.3389/fmed.2024.1346208

3,527 views
3 citations

Original Research

Published on 15 Feb 2024

Assessment of the extent and monetary loss in the selected public hospitals in Jimma Zone, Ethiopia: expired medicine perspectives

in Regulatory Science

Habtamu Getahun
Sileshi Belew
Gemmechu Hasen
Yesuneh Tefera Mekasha
Sultan Suleman

Frontiers in Medicine

doi 10.3389/fmed.2024.1283070

5,517 views
6 citations

Original Research

Published on 08 Feb 2024

Predicting the submission frequency of periodic safety update reports: development and application of the EURD tool

in Regulatory Science

María Gordillo-Marañón
Gianmario Candore
Marta López-Fauqued
Katerina-Christina Deli
Loris Piccolo
Paolo Alcini
Tom Paternoster-Howe
Irene Rager
Robin Ruepp
Menno van der Elst

Frontiers in Medicine

doi 10.3389/fmed.2024.1299190

5,326 views
1 citation

Perspective

Published on 31 Jan 2024

Unlocking the potential of big data and AI in medicine: insights from biobanking

in Regulatory Science

Kaya Akyüz
Mónica Cano Abadía
Melanie Goisauf
Michaela Th. Mayrhofer

Frontiers in Medicine

doi 10.3389/fmed.2024.1336588

6,912 views
18 citations

Original Research

Published on 24 Jan 2024

Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET® in Japan

in Regulatory Science

Takashi Waki
Yusuke Okada
Yuki Kinoshita
Kazuhiro Kajiyama
Chieko Ishiguro
Yuki Nakazato
Ryota Kimura
Harumi Maniwa
Naoya Horiuchi
Toyotaka Iguchi

Frontiers in Medicine

doi 10.3389/fmed.2023.1294696

3,793 views
3 citations

Perspective

Published on 23 Jan 2024

Industry influence on mental health research: depression as a case example

in Regulatory Science

Lisa Cosgrove
Elissa H. Patterson
Harold J. Bursztajn

Frontiers in Medicine

doi 10.3389/fmed.2023.1320304

13,285 views
9 citations

Perspective

Published on 17 Jan 2024

Drug repurposing for rare: progress and opportunities for the rare disease community

in Regulatory Science

Anneliene Hechtelt Jonker
Daniel O’Connor
Maria Cavaller-Bellaubi
Christine Fetro
Maria Gogou
Peter A. C. ’T Hoen
Martin de Kort
Heather Stone
Nivedita Valentine
Anna Maria Gerdina Pasmooij

Frontiers in Medicine

doi 10.3389/fmed.2024.1352803

18,378 views
44 citations

Opinion

Published on 11 Jan 2024

Navigating tensions between public and commercial interests: a case study of open source biosensors for detecting water contaminants in Argentina

in Regulatory Science

Alejandro D. Nadra

Frontiers in Medicine

doi 10.3389/fmed.2024.1268950

1,527 views
1 citation

Perspective

Published on 11 Jan 2024

Opportunities and challenges of traditional Chinese medicine doctors in the era of artificial intelligence

in Regulatory Science

Wenyu Li
Xiaolei Ge
Shuai Liu
Lili Xu
Xu Zhai
Linyong Yu

Frontiers in Medicine

doi 10.3389/fmed.2023.1336175

13,674 views
30 citations

Opinion

Published on 11 Jan 2024

Policy options and practical recommendations for determining priorities in public health research agendas in peripheral countries: insights from a collaborative work initiative in Argentina during the COVID-19 pandemic

in Regulatory Science

Natalia Brenda Fernández
María Georgina Herrera
Matías Blaustein
María Florencia Pignataro

Frontiers in Medicine

doi 10.3389/fmed.2023.1334194

1,737 views

Original Research

Published on 11 Jan 2024

Implementing Horizon Scanning as a tool for the strategic development of regulatory guidelines for nanotechnology-enabled health products

in Regulatory Science

Francisco D. Rodríguez-Gómez
Dominique Monferrer
Oriol Penon
Pilar Rivera-Gil

Frontiers in Medicine

doi 10.3389/fmed.2023.1308047

3,501 views
5 citations

Original Research

Published on 10 Jan 2024

Characteristics of retracted research papers before and during the COVID-19 pandemic

in Regulatory Science

Yuki Furuse

Frontiers in Medicine

doi 10.3389/fmed.2023.1288014

4,674 views
8 citations

Opinion

Published on 09 Jan 2024

Case reports as early safety signals: learning from the COVID-19 vaccination campaign

in Regulatory Science

Michel Goldman
Rebecca E. Chandler

Frontiers in Medicine

doi 10.3389/fmed.2023.1348376

1,658 views
2 citations

Technology and Code

Published on 08 Jan 2024

Will it run?—A proof of concept for smoke testing decentralized data analytics experiments

in Regulatory Science

Sascha Welten
Sven Weber
Adrian Holt
Oya Beyan
Stefan Decker

Frontiers in Medicine

doi 10.3389/fmed.2023.1305415

2,615 views
2 citations

Mini Review

Published on 08 Jan 2024

AI and professional liability assessment in healthcare. A revolution in legal medicine?

in Regulatory Science

Claudio Terranova
Clara Cestonaro
Ludovico Fava
Alessandro Cinquetti

Frontiers in Medicine

doi 10.3389/fmed.2023.1337335

17,470 views
49 citations

Review

Published on 08 Jan 2024

The ménage à trois of healthcare: the actors in after-AI era under patient consent

in Regulatory Science

Riccardo Saccà
Rachele Turrini
Francesco Ausania
Stefania Turrina
Domenico De Leo

Frontiers in Medicine

doi 10.3389/fmed.2023.1329087

3,121 views
5 citations

Systematic Review

Published on 08 Jan 2024

The influence of “industry policy” and “financial institution” configuration effect on innovation performance of China’s biomedical industry-based on necessary condition analysis and qualitative comparative analysis

in Regulatory Science

Yaqiong Zhang

Frontiers in Medicine

doi 10.3389/fmed.2023.1297495

3,645 views
4 citations

Original Research

Published on 05 Jan 2024

Stable closure of acute and chronic wounds and pressure ulcers and control of draining fistulas from osteomyelitis in persons with spinal cord injuries: non-interventional study of MPPT passive immunotherapy delivered via telemedicine in community care

in Regulatory Science

Jeanette Sams-Dodd
Maurizio Belci
Surendra Bandi
Damian Smith
Frank Sams-Dodd

Frontiers in Medicine

doi 10.3389/fmed.2023.1279100

11,602 views
5 citations

518 articles

articles

Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation

Editorial: Women in science - regulatory science 2023

Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors

Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators

Editorial: Reproductive medical care in minors: ethical and liability issues

Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated

Data from the Indian drug regulator and from Clinical Trials Registry-India does not always match

Assessment of the extent and monetary loss in the selected public hospitals in Jimma Zone, Ethiopia: expired medicine perspectives

Predicting the submission frequency of periodic safety update reports: development and application of the EURD tool

Unlocking the potential of big data and AI in medicine: insights from biobanking

Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET® in Japan

Industry influence on mental health research: depression as a case example

Drug repurposing for rare: progress and opportunities for the rare disease community

Navigating tensions between public and commercial interests: a case study of open source biosensors for detecting water contaminants in Argentina

Opportunities and challenges of traditional Chinese medicine doctors in the era of artificial intelligence

Policy options and practical recommendations for determining priorities in public health research agendas in peripheral countries: insights from a collaborative work initiative in Argentina during the COVID-19 pandemic

Implementing Horizon Scanning as a tool for the strategic development of regulatory guidelines for nanotechnology-enabled health products

Characteristics of retracted research papers before and during the COVID-19 pandemic

Case reports as early safety signals: learning from the COVID-19 vaccination campaign

Will it run?—A proof of concept for smoke testing decentralized data analytics experiments

AI and professional liability assessment in healthcare. A revolution in legal medicine?

The ménage à trois of healthcare: the actors in after-AI era under patient consent

The influence of “industry policy” and “financial institution” configuration effect on innovation performance of China’s biomedical industry-based on necessary condition analysis and qualitative comparative analysis

Stable closure of acute and chronic wounds and pressure ulcers and control of draining fistulas from osteomyelitis in persons with spinal cord injuries: non-interventional study of MPPT passive immunotherapy delivered via telemedicine in community care